4
Changes in Ownership
ELITE PHARMACEUTICALS INC /NV/ Filed Acc 0001053369-13-000049
Chief Scientific Officer sold 279,300 shares at an average $0.13 ($35,820)
From the SEC's structured data for this filing
Trades in this filing
NIGALAYE ASHOK G · Chief Scientific Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2013-10-28 | Sale : show line 1 in the form | −139,500 | $0.13 | $18,065 | 22,316,050 | I |
| 2013-10-29 | Sale : show line 2 in the form | −139,800 | $0.13 | $17,755 | 22,176,250 | I |
| Open-market sales · 279,300 sh · avg $0.13 · $35,820 | ||||||
Loading xslF345X03/primary_doc.xml…